The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 07, 2020

Filed:

Oct. 20, 2017
Applicant:

Proteus Digital Health, Inc., Redwood City, CA (US);

Inventors:

Mark Zdeblick, Portola Valley, CA (US);

Andrew Thompson, Portola Valley, CA (US);

Aleksandr Pikelny, Los Angeles, CA (US);

Timothy L. Robertson, Belmont, CA (US);

Hooman Hafezi, Redwood City, CA (US);

Assignee:

PROTEUS DIGITAL HEALTH, INC., Redwood City, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 5/07 (2006.01); A61B 5/00 (2006.01); H01Q 1/27 (2006.01); A61J 3/00 (2006.01); G06K 7/10 (2006.01); A61B 5/1473 (2006.01);
U.S. Cl.
CPC ...
A61B 5/073 (2013.01); A61B 5/0028 (2013.01); A61B 5/0031 (2013.01); A61B 5/07 (2013.01); A61B 5/076 (2013.01); A61B 5/1473 (2013.01); A61B 5/4833 (2013.01); A61B 5/4839 (2013.01); A61B 5/681 (2013.01); A61B 5/6861 (2013.01); A61B 5/7282 (2013.01); A61J 3/007 (2013.01); G06K 7/10168 (2013.01); H01Q 1/273 (2013.01); A61B 2560/0214 (2013.01); A61B 2560/0462 (2013.01); A61B 2562/08 (2013.01); A61B 2562/162 (2013.01); Y10T 29/49117 (2015.01);
Abstract

A system for administering prescription medications including a composition and a receiver. The composition may include an active agent, an identifier, and a pharmaceutically acceptable carrier. The active agent may include a controlled pharmaceutical. The identifier may include: a partial power source having a first material and a second material configured to generate a voltage in contact with a conductive fluid within a body of a patient, and a signal generation component configured to use at least a portion of the generated voltage to transmit a signal through the body of the patient. The receiver may be positioned near the body of the patient, wherein the receiver is configured to: receive the signal transmitted through the body of the patient, and automatically report the signal for at least one of identification of the controlled pharmaceutical or tracking physical administration of the controlled pharmaceutical to the body of the patient.


Find Patent Forward Citations

Loading…